Finding biomarkers for head and neck cancer radiation therapy
Part of Cancer, Mouth & dental clinical trials.
This study is looking for proteins or other substances in the blood (biomarkers) that can help predict how well head and neck cancer patients respond to radiation therapy. If you have head and neck cancer and are scheduled for radiation, possibly with chemo, immunotherapy, or targeted therapy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with head and neck cancer confirmed by a biopsy.
- You are planning to have radiation therapy, possibly with chemotherapy, immunotherapy, or targeted therapy, as a main treatment.
- You are 18 years or older.
- You understand what the study involves and agree to take part by signing a consent form.
- Your cancer has not spread to other parts of the body.
- You have not had radiation to the head or neck before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking for people with head and neck cancer who are about to start radiation therapy (possibly combined with other treatments). The goal is to find biomarkers that may help predict how well the treatment works or what side effects might occur.
This study tests giving a short course of targeted radiation (SBRT) along with immunotherapy and a targeted drug before surgery for advanced head and neck cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.
This study looks at how radiation therapy for head and neck cancer affects swallowing. It may help researchers understand swallowing problems better and find ways to help patients.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
This study looks at immune system signals in your blood during and after postoperative radiation therapy for certain head and neck cancers involving the brain or skull base. Researchers want to see whether these “immune markers” relate to treatment response or side effects.
This trial is testing a new way to use radiation therapy for head and neck cancer by also looking at the bacteria in your mouth and gut. The goal is to see if adjusting the treatment based on your bacteria can improve outcomes and reduce side effects.
Hear when a new Xerostomia Due to Radiotherapy (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.